1413 related articles for article (PubMed ID: 19162229)
1. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
[TBL] [Abstract][Full Text] [Related]
2. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
Wisniewski CS
Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
[TBL] [Abstract][Full Text] [Related]
3. Experience with rufinamide in a pediatric population: a single center's experience.
Vendrame M; Loddenkemper T; Gooty VD; Takeoka M; Rotenberg A; Bergin AM; Eksioglu YZ; Poduri A; Duffy FH; Libenson M; Bourgeois BF; Kothare SV
Pediatr Neurol; 2010 Sep; 43(3):155-8. PubMed ID: 20691934
[TBL] [Abstract][Full Text] [Related]
4. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S
Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
[TBL] [Abstract][Full Text] [Related]
5. First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy.
Kluger G; Haberlandt E; Kurlemann G; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2010 Apr; 17(4):546-8. PubMed ID: 20185372
[TBL] [Abstract][Full Text] [Related]
6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
Lee EH; Yum MS; Ko TS
Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
[TBL] [Abstract][Full Text] [Related]
8. A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.
Elger CE; Stefan H; Mann A; Narurkar M; Sun Y; Perdomo C
Epilepsy Res; 2010 Feb; 88(2-3):255-63. PubMed ID: 20061123
[TBL] [Abstract][Full Text] [Related]
9. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A
Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268
[TBL] [Abstract][Full Text] [Related]
10. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
11. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ
Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645
[TBL] [Abstract][Full Text] [Related]
12. Rufinamide in children and adults in routine clinical practice.
Jaraba S; Santamarina E; Miró J; Toledo M; Molins A; Burcet J; Becerra JL; Raspall M; Pico G; Miravet E; Cano A; Fossas P; Fernández S; Falip M
Acta Neurol Scand; 2017 Jan; 135(1):122-128. PubMed ID: 26923380
[TBL] [Abstract][Full Text] [Related]
13. Rufinamide for refractory epilepsy in a pediatric and young adult population.
Joseph JR; Schultz RJ; Wilfong AA
Epilepsy Res; 2011 Jan; 93(1):87-9. PubMed ID: 21111576
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
Wheless JW; Conry J; Krauss G; Mann A; LoPresti A; Narurkar M
J Child Neurol; 2009 Dec; 24(12):1520-5. PubMed ID: 19955344
[TBL] [Abstract][Full Text] [Related]
15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
16. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures.
Biton V; Krauss G; Vasquez-Santana B; Bibbiani F; Mann A; Perdomo C; Narurkar M
Epilepsia; 2011 Feb; 52(2):234-42. PubMed ID: 20887365
[TBL] [Abstract][Full Text] [Related]
19. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.
Thome-Souza S; Kadish NE; Ramgopal S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Libenson M; Olson H; Peters J; Poduri A; Rotenberg A; Takeoka M; Kothare SV; Kapur K; Bourgeois BF; Loddenkemper T
Epilepsia; 2014 Aug; 55(8):1235-44. PubMed ID: 25070475
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
